From Medscape Oncology

Coverage from the

American Association for Cancer Research (AACR) 2016 Annual Meeting

April 16 - 20, 2016; New Orleans, Louisiana

April 16 - 20, 2016 New Orleans, Louisiana

AACR Implantable Device May Select Appropriate Cancer Therapy A microdevice implanted into tumors may have the potential to select the most appropriate therapy for cancer patients.
Medscape Medical News, April 19, 2016
AACR MammaPrint Shows Which Breast Cancer Patients Can Skip Chemo The first outcome data from a huge European trial show that the 70-gene assay can identify patients who can safety skip chemotherapy.
Medscape Medical News, April 19, 2016
AACR More Patients Living Longer: Latest Immunotherapy Data The latest data for survival on nivolumab are better than those previously seen with ipilimumab, and both show that some patients live for years.
Medscape Medical News, April 18, 2016

Conference News

AACR 'Bad Luck' or Environment? Depends on the Cancer
Medscape Medical News, April 28, 2016
AACR New Drug For New Target: LOXO-101 for NTRK Gene Fusions
Medscape Medical News, April 25, 2016
AACR Adding Risk Markers Improves Breast Cancer Risk Prediction
Medscape Medical News, April 25, 2016
AACR New Neoadjuvant Combination for HER+ Breast Cancer
Medscape Medical News, April 25, 2016
AACR Questions on PD-L1 Diagnostics for Immunotherapy in NSCLC
Medscape Medical News, April 21, 2016
AACR Delay in Radiation Increases Ipsilateral Breast Cancer Risk
Medscape Medical News, April 20, 2016
AACR 'Remarkable' Responses in Rare Merkel-Cell Skin Cancer
Medscape Medical News, April 19, 2016
AACR Hope for Advanced HNSCC at Last From Immunotherapy
Medscape Medical News, April 19, 2016

AACR Implantable Device May Select Appropriate Cancer Therapy
Medscape Medical News, April 19, 2016
AACR MammaPrint Shows Which Breast Cancer Patients Can Skip Chemo
Medscape Medical News, April 19, 2016
AACR Entrectinib: Targeting NTRKs, ROS1, ALK Appears Promising
Medscape Medical News, April 19, 2016
AACR CD4 T-cell Immunotherapy Shows Activity in Solid Tumors
Medscape Medical News, April 18, 2016
AACR BGB-283: Promising Therapy Targeting RAF and RAS Mutations
Medscape Medical News, April 18, 2016
AACR More Patients Living Longer: Latest Immunotherapy Data
Medscape Medical News, April 18, 2016
AACR AACR Meeting Highlights Monumental Moment in Cancer Research
Medscape Medical News, April 13, 2016

Medscape Oncology© WebMD, LLC

Medscape Board at the Podium

Louis Weiner, MD
Georgetown University Medical Center, Washington, DC
Presentation: Combination therapy with immune checkpoint inhibitor and CCK-receptor blockade increases survival of pancreatic cancer
Date: April 19, 2016

Previous Coverage

Related Resources